Past EventThree Firms On The Road To Success

Richard Sayre, PhD., is Chief Science Officer for Spartina Biotechnologies Inc. of Santa Fe. He will present the insights behind Spartina’s innovative technology called SIRENTM that utilizes a two-pronged approach to control COVID-19 without the use of a vaccine. Spartina’s SIREN technology offers a novel treatment for the control of COVID-19 and other viral infections by both stopping the replication of the virus and preventing the virus from suppressing immune system components.

Sergey A. Dryga, Ph.D., MBA, Chief Scientific Officer, NanoDx, Inc. He joined BioDirection (now NanoDx) in 2014 and has extensive experience in building cross-functional R&D teams and leading development of In Vitro Diagnostics, reagents and vaccines. Dr. Dryga is an experienced product-development leader with expertise in nano-biotechnology, molecular biology, protein engineering, system integration, and electrical and software engineering. He is leading development of the nanowire biosensing technology at NanoDx and development of new assays. Dr. Dryga is an inventor on 23 patents and over 30 patent applications.

Dr. Charles “Chuck” Call is CEO of BioFlyte, a venture-backed biodefense and microbial identification company that is commercializing a revolutionary new class of fieldable biological mass spectrometers. Dr. Call is an experienced technology business leader and a technical expert on the transmission, sampling and identification of infectious organisms. His specialties include general management, leadership coaching, start-ups, intellectual property management, technology commercialization, sensors, fluid flow, and aerobiology. 

Moderator: Rick VanNess, Director, Product Management, TriCore Reference Labs